Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Plos One|September 21, 2016
In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013Rana Maroun, Franck Maunoury, Laure Benjamin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple MyelomaIstvan Majer, Sonja Kroep, Rana Maroun, et al.Current Medical Research and Opinion|July 28, 2017
Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance databaseRana Maroun, Laetitia Fleury, Gaelle Nachbaur, et al.BMC Cancer|February 23, 2018
Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional dataRana Maroun, Laura Mitrofan, Laure Benjamin, et al.The American Journal of Managed Care|January 3, 2024
Cost analysis of self-monitoring blood glucose in nonintensively managed type 2 diabetesDavid Kerr, Ian Duncan, Enrico Repetto, et al.Pageof 1